Samuel Kareff, MD, MPH

The MARIPOSA effect 🦋
‼️Awaited OS data for #Amivantamab + lazertinib vs osimertinib in 1L EGFRm advanced #lungcancer presented at #ELCC25

🎯OS HR 0.75 (95%CI: 0.61-0.92)
🎉> 1 yr mOS advantage
🚫no crossover allowed, ⬆️intracranial activity
⬇️toxicity over time w prophylactic mgmt (skin)
#lcsm

27.03.2025 02:25 — 👍 9    🔁 2    💬 0    📌 0

Join us today at noon EST for free #PatientEducation to discuss all things new in the management of Colorectal Cancers @BHCancerCare @BaptistHealthSF @MiamiCancerInst

#CRCSM #PatientEducation

14.03.2025 11:28 — 👍 0    🔁 0    💬 0    📌 0

3 points of progress vs pancreatic cancer!
1. Neoantigen vaccines
www.nature.com/articles/s41...
2. KRAS drugs
www.wsj.com/health/healt...
3. Early diagnosis www.science.org/doi/10.1126/...

01.03.2025 15:26 — 👍 419    🔁 85    💬 8    📌 1

First lecture as faculty yesterday to the @FAUCollegeofMedicine + @WPBVAHCS Pulmonology team. 🫁 cancers are still a team sport in 2025 and beyond! @iaslc.bsky.social @ascocancer.bsky.social @FLASCO_ORG @BHCancerCare

03.01.2025 16:22 — 👍 3    🔁 0    💬 0    📌 0